Show simple item record

dc.contributor.authorYamasaki, K.
dc.contributor.authorMaruyama, T.
dc.contributor.authorChuang, Victor
dc.contributor.authorOtagiri, M.
dc.date.accessioned2017-01-30T11:12:55Z
dc.date.available2017-01-30T11:12:55Z
dc.date.created2014-02-06T20:00:31Z
dc.date.issued2013
dc.identifier.citationYamasaki, Keishi and Chuang, Victor Tuan Giam and Maruyama, Toru and Otagiri, Masaki. 2013. Albumin-drug interaction and its clinical implication. Biochimica et Biophysica Acta - General Subjects. 1830 (12): pp. 5435-5443.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/9478
dc.identifier.doi10.1016/j.bbagen.2013.05.005
dc.description.abstract

Background: Human serum albumin acts as a reservoir and transport protein for endogenous (e.g. fatty acids or bilirubin) and exogenous compounds (e.g. drugs or nutrients) in the blood. The binding of a drug to albumin is a major determinant of its pharmacokinetic and pharmacodynamic profile.Scope of review:The present review discusses recent findings regarding the nature of drug binding sites, drug-albumin binding in certain diseased states or in the presence of coadministered drugs, and the potential of utilizing albumin–drug interactions in clinical applications.Major conclusions: Drug–albumin interactions appear to predominantly occur at one or two specific binding sites. The nature of these drug binding sites has been fundamentally investigated as to location, size, charge, hydrophobicity or changes that can occur under conditions such as the content of the endogenous substances in question. Such findings can be useful tools for the analysis of drug–drug interactions or protein binding in diseased states. A change in protein binding is not always a problem in terms of drug therapy, but it can be used to enhance the efficacy of therapeutic agents or to enhance the accumulation of radiopharmaceuticals to targets for diagnostic purposes. Furthermore, several extracorporeal dialysis procedures using albumin-containing dialysates have proven to be an effective tool for removing endogenous toxins or overdosed drugs from patients. General significance: Recent findings related to albumin–drug interactions as described in this review are useful for providing safer and efficient therapies and diagnoses in clinical settings.

dc.publisherElsevier BV
dc.subjectDisplacement
dc.subjectStructure–function relationship
dc.subjectHuman serum albumin
dc.subjectExtracorporeal albumin dialysis
dc.subjectBinding site
dc.titleAlbumin-drug interaction and its clinical implication
dc.typeJournal Article
dcterms.source.volume1830
dcterms.source.startPage5435
dcterms.source.endPage5443
dcterms.source.issn0304-4165
dcterms.source.titleBiochimica et Biophysica Acta (BBA) - General Subjects
curtin.department
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record